Homovanillic Acid
Research News and Information

Sunday, November 22, 2009

A phase 1 trial of pharmacologic interactions between transdermal selegiline and a 4-hour cocaine infusion.

30 Jul 2009 BACKGROUND: The selective MAO-B inhibitor selegiline has been evaluated in clinical trials as a potential medication for the treatment of cocaine dependence. This study evaluated the safety of and pharmacologic interactions between 7 days of ... Read more...

Prenatal methamphetamine exposure affects the mesolimbic dopaminergic system and behavior in adult offspring.

6 Jul 2009 Methamphetamine is a commonly abused psychostimulant that causes addiction and is often abused by pregnant women. Acute or chronic administration of methamphetamine elevates the levels of the extracellular monoamine neurotransmitters, such as ... Read more...

Ketogenic diet protects dopaminergic neurons against 6-OHDA neurotoxicity via up-regulating glutathione in a rat model of Parkinson's disease.

23 Jun 2009 The high-fat ketogenic diet (KD) leads to an increase of blood ketone bodies (KB) level and has been used to treat refractory childhood seizures for over 80 years. Recent reports show that KD, KB and their components (d-beta-hydroxybutyrate, ... Read more...

Latest indexed articles for 'Homovanillic Acid'

These are the very latest articles for this heading:

• A phase 1 trial of pharmacologic interactions between transdermal selegiline and a 4-hour cocaine infusion. 30 Jul 2009
• Prenatal methamphetamine exposure affects the mesolimbic dopaminergic system and behavior in adult offspring. 6 Jul 2009
• Ketogenic diet protects dopaminergic neurons against 6-OHDA neurotoxicity via up-regulating glutathione in a rat model of Parkinson's disease. 23 Jun 2009
• Biphasic effects of neonatal allopregnanolone on striatal dopamine metabolism. 15 Jun 2009
• Developmental vitamin D deficiency alters dopamine turnover in neonatal rat forebrain. 5 Jun 2009
• Plasma homovanillic acid differences in clinical subgroups of first episode schizophrenic patients. 4 Jun 2009
• Effects of Ningdong granule on the dopamine system of Tourette's syndrome rat models. 21 May 2009
• Central l-proline attenuates stress-induced dopamine and serotonin metabolism in the chick forebrain. 16 May 2009
• Infantile hypokinetic-hypotonic syndrome due to two novel mutations of the tyrosine hydroxylase gene. 28 Apr 2009
• Zonisamide increases dopamine turnover in the striatum of mice and common marmosets treated with MPTP. 27 Apr 2009
• Conversion of dehydrodiferulic acids by human intestinal microbiota. 20 Apr 2009
• Effects of cocaine self-administration history under limited and extended access conditions on in vivo striatal dopamine neurochemistry and acoustic startle in rhesus monkeys. 12 Apr 2009
• Acrylamide decreased dopamine levels and increased 3-nitrotyrosine (3-NT) levels in PC 12 cells. 9 Apr 2009
• In vivo dopamine release and uptake impairments in rats treated with 3-nitropropionic acid. 7 Apr 2009
• Effect of high-fat intake on motor activity, homovanillic acid and 5-hydroxyindoleacetic acid levels in striatum and cortex of rats exposed to stress. 30 Mar 2009
• A history of iron deficiency anemia during infancy alters brain monoamine activity later in juvenile monkeys. 30 Mar 2009
• Metabolism of berry anthocyanins to phenolic acids in humans. 23 Mar 2009
• MPTP-induced model of Parkinson's disease in cytochrome P450 2E1 knockout mice. 15 Mar 2009
• Interleukin-6 is elevated in the cerebrospinal fluid of suicide attempters and related to symptom severity. 4 Mar 2009
• Behavioral and neurochemical profile of m-CPP following exposure to single restraint stress in rat. 27 Feb 2009

See a longer list of these articles.

Technical information about 'Homovanillic Acid'

Chemical name: Benzeneacetic acid, 4-hydroxy-3-methoxy-

Registry Number: 306-08-1

Descriptor UI: D006719

Alternative terms: Homovanillic Acid; Acid, Homovanillic; 3-Methoxy-4-Hydroxyphenylacetic Acid; 3 Methoxy 4 Hydroxyphenylacetic Acid; Acid, 3-Methoxy-4-Hydroxyphenylacetic; 4-Hydroxy-3-Methoxyphenylacetic Acid; 4 Hydroxy 3 Methoxyphenylacetic Acid; Acid, 4-Hydroxy-3-Methoxyphenylacetic;

Allowable Qualifiers: administration & dosage; adverse effects; analogs & derivatives; analysis; antagonists & inhibitors; blood; cerebrospinal fluid; chemical synthesis; classification; diagnostic use; economics; history; immunology; isolation & purification; metabolism; pharmacokinetics; pharmacology; poisoning; radiation effects; standards; supply & distribution; therapeutic use; toxicity; urine; chemistry; contraindications; agonists;

Tree Number: D02.241.223.601.521;

History Note: 86(73); was see under PHENYLACETATES 1975-85, was Prov 1973-74